EKF Diagnostics Holdings has pushed revenue up past £80m and said current trading was strong. The AIM-listed global diagnostics business, which also announced details of a share buyback programme, said its focus is on returning its core business to pre-pandemic 2019 levels and positioning for future sustainable growth outside of short-term contract manufacturing.
Read More